PROMOMED has been awarded three IP RUSSIA AWARDS 2025

November 19th, Moscow

According to the results of the 7th annual Russian Intellectual property Award IP Russia Awards (IPRA), PROMOMED won prizes in three key nominations for practical cases in the field of protection, protection and commercialization of innovations. The expert jury particularly noted the company's responsible approach to creating a full-fledged ecosystem of intellectual property management.

In the nomination "The Best REED protection and Management Strategy in the pharmaceutical industry", PROMOMED case was awarded for creating a reliable integrated protection system for the development of innovative molecules in a short time. The implementation of such a complex project was made possible by the close collaboration of scientists at the R&D Center and patent specialists, as well as the use of an AI platform to accelerate the selection of candidate molecules at the early stages of research.

In the field of commercialization of exclusive rights, the victory was brought by a unique brand strategy of drugs intended for the treatment of obesity and type 2 diabetes. Despite the dense competitive environment, the Company's specialists created and registered memorable brands in record time, which made it possible to bring products to the market and completely eliminate the appearance of counterfeit goods.

The jury paid special attention to the precedent dispute over the "threat of violation", in which PROMOMED managed to preserve the registration of a domestic drug and the maximum selling price for it. This experience has established new standards of evidence in the practice of protecting exclusive rights in the pharmaceutical industry.

Every victory is based on practically significant results. In the last two years alone, PROMMED has received more than 50 patents for inventions, including new molecules, manufacturing technologies and solutions in the field of medical applications. The Company was able to achieve such results thanks to the consistent and professional work of intellectual property specialists. So, in the fall of 2025Maria Porokhnya, Director of Intellectual Property at PROMMED, was awarded the medal "Best Employee of the Patent Service" by the decision of the Association of Technology and Innovation Support Centers.

"Intellectual property in pharmaceuticals is the basis of innovative development. Without reliable patent protection, the most promising scientific developments will not receive investments and will not reach patients.MariaGunpowder. — Today we are witnessing how the Russian pharmaceutical industry is confidently developing its own breakthrough drugs. The awards received are a recognition of our team's high standards in the field of protection, protection and management of intellectual property, which serve as the foundation for creating medicines of the future."